David Lee. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Antineoplastic Agents/therapeutic useAntineoplastic Combined Chemotherapy Protocols/therapeutic useCarcinoma, Non-Small-Cell Lung/drug therapyClinical Trials, Phase II as TopicDocetaxelErbB Receptors/drug effectsGefitinibHumansLung Neoplasms/drug therapyPiperidines/therapeutic useProtein Kinase Inhibitors/therapeutic useQuinazolines/therapeutic useReceptors, Vascular Endothelial Growth Factor/drug effectsTaxoids/therapeutic use
Substances: See more » Antineoplastic AgentsPiperidinesProtein Kinase InhibitorsQuinazolinesTaxoidsDocetaxelErbB ReceptorsReceptors, Vascular Endothelial Growth FactorGefitinibvandetanib
Year: 2005 PMID: 16179094 DOI: 10.1016/S1525-7304(11)70394-1
Source DB: PubMed Journal: Clin Lung Cancer ISSN: 1525-7304 Impact factor: 4.785